Novo Holdings A/S’s Eledon Pharmaceuticals ELDN Stock Holding History

Novo Holdings A/S’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-796	Closed	-$711K	–	18
2016 Q2	$711K	Sell	796 -2,111	-73%	-$2.33M	0.07%	18
2016 Q1	$2.64M	Hold	2,907	–	–	0.29%	15
2015 Q4	$4.11M	Sell	2,907 -4,737	-62%	-$8.25M	0.39%	12
2015 Q3	$12.8M	Hold	7,644	–	–	1.32%	12
2015 Q2	$16.5M	Buy	7,644 +334	+5%	+$646K	1.18%	13
2015 Q1	$13.4M	Buy	7,310 +32	+0.4%	+$70.6K	1.14%	11
2014 Q4	$17.4M	Buy	7,278 +642	+10%	+$1.52M	1.41%	12
2014 Q3	$15.5M	Buy	+6,636	New	+$18.9M	1.51%	11

Other funds holding ELDN

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Novo Holdings A/S's ELDN Position: Q3 2016 in Review

Novo Holdings A/S sold out of Eledon Pharmaceuticals (ELDN) in Q3 2016, closing a stake of 796 shares — an estimated $711K sold.

Novo Holdings A/S first reported a position in ELDN in Q3 2014 and held it in 8 quarters. The position peaked at $17.4M in Q4 2014. 44 funds tracked by Wall St. Rank hold ELDN as of Q3 2016.

Novo Holdings A/S reported no remaining Eledon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Novo Holdings A/S sold 796 Eledon Pharmaceuticals shares in Q3 2016, an estimated $711K.
Novo Holdings A/S first reported a position in Eledon Pharmaceuticals in Q3 2014 and held it in 8 quarters.
Novo Holdings A/S's Eledon Pharmaceuticals position peaked at $17.4M in Q4 2014.
44 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2016.

Based on Novo Holdings A/S's 13F filing for Q3 2016, filed 14 Nov 2016.